Moreover, since KiSS-1 is up-regulated by the treatment of NSCLC with HDAC inhibitors [21], we analyzed KiSS-1-derived peptides in supernatants of cells treated with the drug combinations, as well as the effect of exogenous KPs on sensitivity to cisplatin. Here, KISS1 is linked to non-small cell lung carcinoma.